LU85081A1 - Medicament et composition medicamenteuse pour le traitement et/ou la prevention des maladies de la peau mettant en jeu un processus inflammatoire - Google Patents

Medicament et composition medicamenteuse pour le traitement et/ou la prevention des maladies de la peau mettant en jeu un processus inflammatoire Download PDF

Info

Publication number
LU85081A1
LU85081A1 LU85081A LU85081A LU85081A1 LU 85081 A1 LU85081 A1 LU 85081A1 LU 85081 A LU85081 A LU 85081A LU 85081 A LU85081 A LU 85081A LU 85081 A1 LU85081 A1 LU 85081A1
Authority
LU
Luxembourg
Prior art keywords
keratin
skin
polymer
composition
composition according
Prior art date
Application number
LU85081A
Other languages
English (en)
French (fr)
Inventor
Brod Joel
Kermici Michel
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Priority to LU85081A priority Critical patent/LU85081A1/fr
Priority to PCT/FR1984/000253 priority patent/WO1985002120A1/fr
Priority to EP84402242A priority patent/EP0147261B1/fr
Priority to JP59504078A priority patent/JPS61500359A/ja
Priority to DE8484402242T priority patent/DE3482754D1/de
Priority to CA000467386A priority patent/CA1244762A/fr
Publication of LU85081A1 publication Critical patent/LU85081A1/fr
Priority to US07/095,897 priority patent/US4959213A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4741—Keratin; Cytokeratin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/842—Skin; hair; nails; sebaceous glands; cerumen

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Birds (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
LU85081A 1983-11-09 1983-11-09 Medicament et composition medicamenteuse pour le traitement et/ou la prevention des maladies de la peau mettant en jeu un processus inflammatoire LU85081A1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
LU85081A LU85081A1 (fr) 1983-11-09 1983-11-09 Medicament et composition medicamenteuse pour le traitement et/ou la prevention des maladies de la peau mettant en jeu un processus inflammatoire
PCT/FR1984/000253 WO1985002120A1 (fr) 1983-11-09 1984-11-07 Medicament et composition medicamenteuse pour le traitement et/ou la prevention des maladies de la peau mettant en jeu un processus inflammatoire
EP84402242A EP0147261B1 (fr) 1983-11-09 1984-11-07 Médicament et composition médicamenteuse pour le traitment et/ou la prevention des maladies de la peau mettant en jeu un processus inflammatoire
JP59504078A JPS61500359A (ja) 1983-11-09 1984-11-07 炎症過程を伴う皮膚疾患の治療および（または）予防用薬剤および薬剤組成物
DE8484402242T DE3482754D1 (de) 1983-11-09 1984-11-07 Medikament und medikamentoese zusammensetzung zur behandlung und/oder verhinderung von hautkrankheiten, verursacht durch eine entzuendung.
CA000467386A CA1244762A (fr) 1983-11-09 1984-11-08 Composition pharmaceutique pour le traitement et/ou la prevention des maladies de la peau mettant en jeu un processus inflammatoire
US07/095,897 US4959213A (en) 1983-11-09 1987-09-14 Pharmaceutical composition for treatment and/or prevention of diseases of the skin involving an inflammatory process

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LU85081A LU85081A1 (fr) 1983-11-09 1983-11-09 Medicament et composition medicamenteuse pour le traitement et/ou la prevention des maladies de la peau mettant en jeu un processus inflammatoire
LU85081 1983-11-09

Publications (1)

Publication Number Publication Date
LU85081A1 true LU85081A1 (fr) 1985-07-17

Family

ID=19730169

Family Applications (1)

Application Number Title Priority Date Filing Date
LU85081A LU85081A1 (fr) 1983-11-09 1983-11-09 Medicament et composition medicamenteuse pour le traitement et/ou la prevention des maladies de la peau mettant en jeu un processus inflammatoire

Country Status (7)

Country Link
US (1) US4959213A (ja)
EP (1) EP0147261B1 (ja)
JP (1) JPS61500359A (ja)
CA (1) CA1244762A (ja)
DE (1) DE3482754D1 (ja)
LU (1) LU85081A1 (ja)
WO (1) WO1985002120A1 (ja)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5358935A (en) * 1992-11-19 1994-10-25 Robert Allen Smith Nonantigenic keratinous protein material
US5932552A (en) 1997-11-26 1999-08-03 Keraplast Technologies Ltd. Keratin-based hydrogel for biomedical applications and method of production
US6270791B1 (en) * 1999-06-11 2001-08-07 Keraplast Technologies, Ltd. Soluble keratin peptide
US6544548B1 (en) 1999-09-13 2003-04-08 Keraplast Technologies, Ltd. Keratin-based powders and hydrogel for pharmaceutical applications
US6783546B2 (en) 1999-09-13 2004-08-31 Keraplast Technologies, Ltd. Implantable prosthetic or tissue expanding device
US6270793B1 (en) 1999-09-13 2001-08-07 Keraplast Technologies, Ltd. Absorbent keratin wound dressing
US6371984B1 (en) 1999-09-13 2002-04-16 Keraplast Technologies, Ltd. Implantable prosthetic or tissue expanding device
US6461628B1 (en) 1999-09-13 2002-10-08 Keraplast Technologies, Ltd. Non-woven keratin cell scaffold
US6316598B1 (en) 1999-09-13 2001-11-13 Keraplast Technologies, Ltd. Water absorbent keratin and gel formed therefrom
WO2003035722A1 (en) * 2001-09-25 2003-05-01 Southwest Research Institute Methods for controlling peptide solubility, chemically modified peptides, and stable solvent systems for producing same
EP1478328B1 (en) * 2002-01-28 2013-06-05 Keraplast Technologies Ltd. Bioactive keratin peptides
US6989437B2 (en) * 2002-04-10 2006-01-24 Keraplast Technologies, Ltd. Methods for producing, films comprising, and methods for using heterogeneous crosslinked protein networks
US6914126B2 (en) * 2002-04-10 2005-07-05 Keraplast Technologies, Ltd. Methods for producing, films comprising, and methods for using heterogenous crosslinked protein networks
US7001987B2 (en) 2002-04-22 2006-02-21 Keraplast Technologies, Ltd. Hydrogel with controllable mechanical, chemical, and biological properties and method for making same
US20040082717A1 (en) * 2002-06-24 2004-04-29 Southwest Research Institute Keratin-silicone copolymers and interpenetrating networks (IPN's), methods of production and methods of use thereof
WO2007001339A2 (en) 2004-08-17 2007-01-04 Wake Forest University Health Sciences Ambient stored blood plasma expanders
US8920827B2 (en) 2005-10-21 2014-12-30 Wake Forest University Health Sciences Keratin bioceramic compositions
US7892573B2 (en) 2006-02-10 2011-02-22 Wake Forest University Health Sciences Nerve regeneration employing keratin biomaterials
US8273702B2 (en) * 2006-02-17 2012-09-25 Wake Forest University Health Sciences Wound healing compositions containing keratin biomaterials
US9149566B2 (en) 2006-02-17 2015-10-06 Wake Forest University Health Sciences Coatings and biomedical implants formed from keratin biomaterials
US7252816B1 (en) 2006-03-29 2007-08-07 Dow Pharmaceutical Sciences Topical acne vulgairs medication with a sunscreen
US8604901B2 (en) * 2006-06-27 2013-12-10 Eyelock, Inc. Ensuring the provenance of passengers at a transportation facility
BRPI0705059B1 (pt) * 2007-06-28 2016-05-31 Univ Rio De Janeiro hidrolisados de queratina, processo para sua produção e composições cosméticas contendo os mesmos
US20090041686A1 (en) * 2007-08-06 2009-02-12 Osborne David W Topical acne vulgaris composition with a sunscreen
US20090047260A1 (en) * 2007-08-17 2009-02-19 Wake Forest University Health Sciences Keratin biomaterials for cell culture and methods of use
WO2010093882A1 (en) 2009-02-13 2010-08-19 Wake Forest University Health Sciences Keratin biomaterials for cell culture and methods of use
US9045600B2 (en) 2009-05-13 2015-06-02 Keraplast Technologies, Ltd. Biopolymer materials
AU2011222540B2 (en) * 2010-03-05 2016-09-29 Wake Forest University Health Sciences Controlled delivery system
WO2011112575A1 (en) * 2010-03-08 2011-09-15 Wake Forest University Health Sciences Keratin biomaterials for treatment of ischemia
AU2011329839B2 (en) 2010-11-17 2016-12-08 Wake Forest University Health Sciences Keratin compositions for treatment of bone deficiency or injury
CN112724229B (zh) * 2019-10-28 2023-09-26 中国医学科学院药物研究所 一种角蛋白bd-4、制法和其药物组合物与用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH188317A (de) * 1936-02-24 1936-12-31 A Wuelfing Johann Verfahren zur Herstellung eines schwefelreichen, wasserlöslichen Gemisches von höhermolekularen Keratinabbauprodukten.
US3033755A (en) * 1961-04-14 1962-05-08 Kolmar Laboratories Process for removing the water soluble materials from a keratin structure and cosmetic or pharmaceutical product formed therefrom
US3660566A (en) * 1969-06-12 1972-05-02 Lever Brothers Ltd Extraction of lipid and cellular fractions from the stratum corneum of animal skin
JPS603104B2 (ja) * 1977-03-07 1985-01-25 積水化学工業株式会社 改良されたケラチン含有物質の製造方法
DE3014123C2 (de) * 1980-04-12 1982-03-18 B. Braun Melsungen Ag, 3508 Melsungen Verfahren zur Herstellung von Skleroproteintransplantaten mit erhöhter biologischer Stabilität

Also Published As

Publication number Publication date
CA1244762A (fr) 1988-11-15
EP0147261A2 (fr) 1985-07-03
JPS61500359A (ja) 1986-03-06
EP0147261B1 (fr) 1990-07-18
WO1985002120A1 (fr) 1985-05-23
US4959213A (en) 1990-09-25
DE3482754D1 (de) 1990-08-23
EP0147261A3 (en) 1985-08-07

Similar Documents

Publication Publication Date Title
LU85081A1 (fr) Medicament et composition medicamenteuse pour le traitement et/ou la prevention des maladies de la peau mettant en jeu un processus inflammatoire
EP0586392B1 (fr) Procede de separation d'un compose vegetal
WO2018197731A1 (fr) Extrait de 20-hydroxyecdysone de qualité pharmaceutique, son utilisation et sa préparation
WO2001091696A2 (fr) Utilisation de derives de biguanide pour fabriquer un medicament ayant un effet cicatrisant
EP2254551B1 (fr) Gel de sucralfate sterilisé
BE1004915A3 (fr) Collagene, procede pour le preparer, et agent cosmetique le contenant.
FR2755015A1 (fr) Utilisation d'un extrait flavonoidique de ginkgo biloba substantiellement depourvu de terpenes, dans le domaine buccodentaire, et composition contenant un tel extrait
FR2503561A1 (fr) Film flexible continu a usage cosmetique et pharmaceutique contenant des polypeptides
OA11026A (fr) Gel antimycosique à forte libération de substance active
WO2014184340A1 (fr) Composition d'extraits d'ilex aquifolium et son utilisation
FR2741266A1 (fr) Stimulation du metabolisme cellulaire par une proteine fixant reversiblement l'oxygene, celle-ci permettant la potentialisation de l'activite d'autres substances a vocation therapeutique ou cosmetique
EP0308456B1 (fr) Composition pour le traitement de l'epiderme
CH676325A5 (ja)
FR2635459A1 (fr) Procede de fabrication de microspheres par reticulation de proteines, microspheres ainsi obtenues et leurs utilisations
EP0228978A1 (fr) Compositions à usage thérapeutique comprenant des composés organo-siliciés
EP0099780B1 (fr) Dérivé kératinique, son procédé de préparation et composition de traitement le contenant
CA2493074A1 (fr) Elevation du taux d'heme oxygenase avec des derives de la rheine
WO2003000208A1 (fr) Composition a usage topique comprenant un produit cytotoxique
WO1999063964A1 (fr) Procede de preparation de fibrilline a partir de cnidaires, et compositions obtenues utilisables en cosmetiques
FR2999085A1 (fr) Utilisation d'un extrait de levure pour augmenter la synthese de peptides antimicrobiens
BE856652A (fr) Composition pharmaceutique pour le traitement des troubles du sommeil
BE886485A (fr) Composition d'acide 2-(3-benzoylphenyl)-propionique (ketoprofene, dci) micro-encapsule pour usage therapeutique oral a action prolongee
EP0005404A2 (fr) Produit cicatrisant extrait de la moelle osseuse d'animaux
WO2012114051A1 (fr) Compositions pharmaceutiques administrables par voie cutanée et destinées au traitement local de la dermatite atopique canine
FR2555051A1 (fr) Nouveau medicament constitue d'une huile peroxydee obtenue par transformation biologique a faible energie